Results 211 to 220 of about 492,171 (290)

Early screening for respiratory and cardiac complications in pediatric mucopolysaccharidosis IVA: Insights from a case. [PDF]

Intractable Rare Dis Res
Shu H, Shang X, Sun Y, Li G, Chen C, Yang J.   +5 more
europepmc   +1 more source

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB

JIMD Reports, Volume 67, Issue 3, May 2026.
ABSTRACT Mucopolysaccharidosis Type IV is a multisystem lysosomal storage disease characterized by severe skeletal dysplasia resulting from impaired degradation of the glycosaminoglycans keratan sulfate and chondroitin‐6‐sulfate. The condition is classified into Types A and B based on the underlying enzyme deficiency.
Mark Wijnen, Evert F. S. van Velsen, J. Gert‐Jan Milhous, Esmee Oussoren, Bram C. J. van der Eerden, Margreet A. E. M. Wagenmakers   +5 more
wiley   +1 more source

Recent advances in mucopolysaccharidosis IVA treatment. [PDF]

Orphanet J Rare Dis
Leal AF, Pachajoa H.
europepmc   +1 more source

Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T‐Cell Biomarkers

The Laryngoscope, Volume 136, Issue 5, Page 2189-2198, May 2026.
ABSTRACT Objective Head and neck squamous cell carcinoma (HNSCC) lacks reliable prognostic circulating biomarkers, and the role of the immune system in its progression remains incompletely understood. This study aimed to evaluate the prognostic value of systemic inflammatory and immune biomarkers in surgically treated patients with primary oral cavity (
Riccardo Gili, Paola Lovino Camerino, Luca Lalli, Elisa Bellini, Chiara Tagliaferri, Filippo Bruno Lanza, Stefania Vecchio, Simone Caprioli, Giorgio Peretti, Lucia Del Mastro, Filippo Marchi   +10 more
wiley   +1 more source

Outcomes and prognostic markers in locally advanced head and neck squamous cell carcinoma underwent chemoradiotherapy. [PDF]

Discov Oncol
Bölek H, Kayaalp M, Babayiğit Y, Duru Birgi S, Yaşar HA.   +4 more
europepmc   +1 more source

Progress Toward Efficient Wide‐Gap Cu(In,Ga)(S,Se)2 Thin‐Film Solar Cells

Progress in Photovoltaics: Research and Applications, Volume 34, Issue 5, Page 567-588, May 2026.
Wide‐gap Cu (In,Ga)(S,Se)2 thin‐film solar cells are studied in view of their performance, limitations, and opportunities for further optimization. Different sources of open circuit voltage limitations were discussed and weighted. Interface recombination appears the main recombination channel, which however can be influenced heavy alkali treatment ...
Setareh Zahedi‐Azad, Roland Scheer, Dimitrios Hariskos, Stefan Paetel, Wolfram Hempel, Wolfram Witte, Hao Luo, Oana Cojocaru‐Mirédin, Mary Blankenship, Dirk Hauschild, Victor van Maris, Lothar Weinhardt, Clemens Heske, Thomas Unold, José A. Márquez, Jasmin Seeger, Florian Wilhelmi, Michael Hetterich, Thomas Niesen, Patrick Eraerds, Thomas Dalibor, Xiaowei Jin, Reinhard Schneider, Dagmar Gerthsen, Di Wang, Christian Kübel   +25 more
wiley   +1 more source

Case Report: Two infants with hypercalcemia of rare and distinct etiologies. [PDF]

Front Endocrinol (Lausanne)
Ahel IB, Andritsos V, Košuljandić Đ, Severinski S, Ješić M, Grozdanić KL, Dekanić KB, Jambrović J, Čače IB.   +8 more
europepmc   +1 more source

Pleuritis Induced by Brigatinib During the Treatment of Non‐Small Cell Lung Cancer

Respirology Case Reports, Volume 14, Issue 5, May 2026.
This is the first reported case of brigatinib‐induced pleuritis in ALK‐positive lung cancer. Pleural effusion resolved after discontinuation and did not recur at a reduced dose of 30 mg/day. Dose reduction to 30 mg/day could be a safe and effective management strategy in selected patients.
Shohei Yano, Moon Hee Hwang, Tomoko Harima, Shota Takahashi, Takumi Yamada, Nao Yoshida, Yuki Yoshida, Atsushi Hirai   +7 more
wiley   +1 more source

Quantification of glycosaminoglycans in dried blood spots, and evaluation of its usefulness as a secondary newborn screening test for mucopolysaccharidoses. [PDF]

Biochem Biophys Rep
Oboshi W, Hirakiyama A, Miura M, Omachi H, Tanaka M, Seo JH, Ohtake A, Osawa Y, Ishige M, Kosuga M, Munenaga T, Migita O, Nyuzuki H, Sasai H, Fukuda T, Sano S, Ito T, Bo R, Takeshima Y, Esaki H, Inoue T, Nagamitsu S, Watanabe Y, Nakamura K, Sawada H, Maruyama S, Murayama K, Okuyama T.   +27 more
europepmc   +1 more source

Paradoxical Pyogenic Granuloma Associated With Ramucirumab but Not Bevacizumab: A Case Suggesting Differential Effects of VEGF Receptor and Ligand Inhibition

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We report a case of multifocal pyogenic granuloma that developed during ramucirumab therapy but did not recur after switching to bevacizumab. ABSTRACT Pyogenic granuloma is a benign vascular lesion that may bleed repeatedly and impair daily activities.
Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou   +3 more
wiley   +1 more source